公司资料
Agilent Technologies 股价、新闻与催化剂
- 股票代码:
- A
- 交易所:
- NYSE
- 行业:
- MedTech
- 所在地:
- United States
股票表现
169.33 USD (-1.14%)
收盘价
最后更新: 2026年10月6日
38.1B USD
市值
股价为何变动
截至 2026年10月6日，A 下跌 1.14%，收于 $169.33。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Analytical and Clinical Laboratory Technology Company
Agilent Technologies supplies instruments, software, consumables, services, and laboratory expertise to pharmaceutical, biotechnology, diagnostics, chemical, food, environmental, and academic customers. Its products support scientific measurement from discovery through regulated manufacturing and quality control.
Life Sciences and Diagnostics Markets Group
The Life Sciences and Diagnostics Markets Group provides chromatography, mass spectrometry, genomics, pathology, and companion-diagnostics solutions. These technologies are used in drug discovery, biomarker research, clinical testing, and the characterization of biologic and small-molecule medicines.
CrossLab Services and Consumables
Agilent CrossLab provides instrument services, compliance support, laboratory management, supplies, and recurring consumables. The business serves both Agilent and third-party installed instruments, creating a service and replacement-cycle relationship with laboratories.
Applied Markets Group
The Applied Markets Group serves food safety, environmental testing, chemicals, energy, and materials science. Its analytical instruments help customers identify contaminants, characterize compounds, monitor industrial processes, and satisfy regulatory requirements.
Integrated Laboratory Workflow Strategy
Agilent combines hardware with software, consumables, automation, and services to embed its technology in repeatable laboratory workflows. The breadth of this model provides exposure to both capital-equipment purchases and recurring revenue from instrument use.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。